Recent Advances in the Prevention of Respiratory Syncytial Virus in Pediatrics
- Madeline Lipp; Kerry Empey
Access Resources
About
This review article highlights new developments in respiratory syncytial virus (RSV) prevention in pediatric patients and safety considerations for clinical trials. It describes two new treatments approved in 2023: a vaccine for pregnant women and an antibody treatment, both reducing RSV-related infections. The field is growing with more trials exploring different methods to protect infants and kids from RSV. While these advancements are promising, it emphasizes the need for careful study of risks and long-term safety through thorough clinical trials and monitoring after approval to ensure safe use of these prevention strategies over time.
Tags
More like this
The information provided on this website is for educational purposes only. It does not substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.